Tissue Perfusion and Blood Flow Monitoring Technology
Completed
- Conditions
- Wounds and Injuries
- Registration Number
- NCT01139567
- Lead Sponsor
- CW Optics, Inc.
- Brief Summary
The purpose of this study is to investigate the safety and efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. The hypothesis is that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of blood flow velocity measurements of wound sites to assess tissue viability with a novel optical device. Comparison between the responses of patients treated with hyperbaric oxygen therapy and those treated by other means will be made. 2 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chippenham and Johnston-Willis Medical Center
🇺🇸Richmond, Virginia, United States